Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Maze Therapeutics agreed with Frazier Life Sciences funds to exchange 2,776,007 common shares for pre-funded warrants exercisable at $0.001, subject to a 9.99% ownership blocker. The reported post-exchange share figure is truncated in the source.
Maze Therapeutics exchanged 2,776,007 common shares held by Frazier Life Sciences funds for pre-funded warrants on October 15, 2026. The warrants cover 2,776,007 common shares at an exercise price of $0.001 per share. Exercise is permitted immediately but restricted if holders’ beneficial ownership would exceed 9.99%,